BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 27139836)

  • 41. CYP3A4 and CYP3A5 genotyping by Pyrosequencing.
    Garsa AA; McLeod HL; Marsh S
    BMC Med Genet; 2005 May; 6():19. PubMed ID: 15882469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populations.
    Schirmer M; Toliat MR; Haberl M; Suk A; Kamdem LK; Klein K; Brockmöller J; Nürnberg P; Zanger UM; Wojnowski L
    Pharmacogenet Genomics; 2006 Jan; 16(1):59-71. PubMed ID: 16344723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic variants of CYP3A4 and CYP3A5 in cynomolgus and rhesus macaques.
    Uno Y; Matsushita A; Osada N; Uehara S; Kohara S; Nagata R; Fukuzaki K; Utoh M; Murayama N; Yamazaki H
    Drug Metab Dispos; 2010 Feb; 38(2):209-14. PubMed ID: 19910514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations from Morocco and Tunisia.
    Novillo A; Romero-Lorca A; Gaibar M; Bahri R; Harich N; Sánchez-Cuenca D; Esteban E; Fernández-Santander A
    Int J Biol Markers; 2015 Feb; 30(1):e148-51. PubMed ID: 25385241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrasting exome constancy and regulatory region variation in the gene encoding CYP3A4: an examination of the extent and potential implications.
    Creemer OJ; Ansari-Pour N; Ekong R; Tarekegn A; Plaster C; Bains RK; Itan Y; Bekele E; Bradman N
    Pharmacogenet Genomics; 2016 Jun; 26(6):255-70. PubMed ID: 27139836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic contribution to variable human CYP3A-mediated metabolism.
    Lamba JK; Lin YS; Schuetz EG; Thummel KE
    Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variation in Expression of Cytochrome P450 3A Isoforms and Toxicological Effects: Endo- and Exogenous Substances as Regulatory Factors and Substrates.
    Fujino C; Sanoh S; Katsura T
    Biol Pharm Bull; 2021; 44(11):1617-1634. PubMed ID: 34719640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The missing linkage: what pharmacogenetic associations are left to find in CYP3A?
    Perera MA
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):17-28. PubMed ID: 19968573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.
    Li H; Lampe JN
    Arch Biochem Biophys; 2019 Sep; 673():108078. PubMed ID: 31445893
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.